- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.11. | IMAC Holdings Receives Notification Of Deficiency From Nasdaq Related To Delayed Filing Of Quarterly Report On Form 10-Q | 2 | Reuters | ||
| 22.11. | IMAC Holdings receives non-compliance notice from Nasdaq | 2 | Seeking Alpha | ||
| 22.11. | IMAC Holdings, Inc.: IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q | 56 | GlobeNewswire (Europe) | FRANKLIN, TN, Nov. 22, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing... ► Artikel lesen | |
| 22.11. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 15.11. | IMAC Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 14.11. | Imac Holdings-Aktie erreicht 52-Wochen-Tief bei 1,02 US-Dollar | 2 | Investing.com Deutsch | ||
| 14.11. | Imac Holdings stock hits 52-week low at $1.02 | 1 | Investing.com | ||
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 14.11. | IMAC Holdings, Inc.: IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c) | 70 | GlobeNewswire (Europe) | FRANKLIN, TN, Nov. 14, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it has received an exception from the Listing Qualifications Staff... ► Artikel lesen | |
| 13.11. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 23.10. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.09. | IMAC Holdings welcomes Jeffrey Busch to its Board of Directors | 2 | Investing.com | ||
| 25.09. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.09. | Imac Holdings stock hits 52-week low at $1.2 amid market challenges | 1 | Investing.com | ||
| 19.09. | IMAC Holdings, Inc.: IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology | 1 | GlobeNewswire (USA) | ||
| 13.09. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.08. | IMAC Holdings receives notification of deficiency from Nasdaq | 1 | Seeking Alpha | ||
| 23.08. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.08. | IMAC Holdings, Inc.: IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q | 361 | GlobeNewswire (Europe) | FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing... ► Artikel lesen | |
| 30.07. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.07. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings |
Seite:
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 1,210 | -0,49 % | Plus Therapeutics Inc.: Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Obtained agreement from FDA to initiate a Phase 1 trial evaluating multiple doses of Rhenium (186Re) Obisbemeda for the treatment of patients with leptomeningeal metastases (LM) Presented positive... ► Artikel lesen | |
| ASENSUS SURGICAL | 0,305 | 0,00 % | KARL STORZ akquiriert den US-amerikanischen Robotik-Spezialisten Asensus Surgical | Tuttlingen / Research Triangle Park, USA (ots) - Das familiengeführte und international agierende Medizintechnikunternehmen KARL STORZ gibt die Akquisition des innovativen Robotik-Spezialisten Asensus... ► Artikel lesen | |
| MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve president, CEO Preiner resigns | ||
| LIFEWARD | 2,140 | +3,88 % | Lifeward Ltd. Direktor Michael Swinford kauft Aktien im Wert von 43.858 US-Dollar | ||
| EKSO BIONICS | 0,710 | +4,41 % | Ekso Bionics stock hits 52-week low at $0.67 amid market challenges | ||
| IMUNON | 0,830 | +1,22 % | Imunon, Inc.: IMUNON Announces Results from its End-of-Phase 2 Meeting with the FDA for its Lead IMNN-001 Clinical Program in Advanced Ovarian Cancer | FDA Project Team supports the company's proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment schedule, and primary endpoint Final Protocol submission... ► Artikel lesen | |
| ROCKWELL MEDICAL | 2,140 | -0,93 % | Q2 EPS Estimates for Rockwell Medical Cut by HC Wainwright | ||
| AVINGER | 0,848 | +4,67 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| VIRIDIAN THERAPEUTICS | 21,000 | +2,94 % | Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data | WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 4,050 | 0,00 % | Sintx Technologies, Inc. - 8-K, Current Report | ||
| AETHLON MEDICAL | 0,354 | +4,73 % | Aethlon Medical, Inc.: Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update | Achieves Key Milestone with Enrollment of First Two Patients in the Safety, Feasibility, and Dose Finding Study of Aethlon's Hemopurifier® in Patients with Solid... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order | TORONTO, ON / ACCESSWIRE / July 9, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene... ► Artikel lesen | |
| NEURONETICS | 0,907 | 0,00 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve... ► Artikel lesen | |
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
| HVIVO | 0,252 | 0,00 % | hVIVO PLC - Presentation at Jefferies London Healthcare Conf |
IMAC HOLDINGS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,110 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMAC HOLDINGS INC finden Sie auf Wallstreet Online.
